Please assess the completion status of the following clinical trial:

Trial Title: Mobile Diabetes Management

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetic \[patient\]~* A1c equal to or greater than 7.5 \[patient\]~* 18-64 years of age at time of recruitment \[patient\]~* Access to the internet (does not need to be at their home, elsewhere is fine e.g. work) \[patient\]~* E-mail account \[patient\]~* Must speak English \[patient\]~Exclusion Criteria:~* No insulin pump \[patient\]~* No current alcohol or drug abuse- must be sober 1 year \[patient\]~* Not currently pregnant \[patient\]~* No terminal diagnosis \[patient\]~* No dementia or Alzheimer's \[patient\]~* No active chemotherapy \[patient\]~* No significant hearing impairment \[patient\]~* Poorly corrected vision that would impede use of phone \[patient\]~* No mute or aphasia \[patient\]~* No diagnosis of schizophrenia, bipolar disorder, or major psychosis \[patient\]~* No Medicaid or Medicare~* No uninsured

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 64 Years
- Healthy Volunteers: f

Study Arms:
- Group 1: Usual Care (Type: NO_INTERVENTION): Provider-driven care, based in office, no special diabetes management; Patient self-monitoring of blood glucose (SMBG)
- Group 2: patient intervention (Type: ACTIVE_COMPARATOR): Home diabetes monitoring by patient using mobile phone to communicate information and receive feedback
- Group 3: patient-physician intervention (Type: ACTIVE_COMPARATOR): Home diabetes monitoring by patient using mobile phone to communicate and receive feedback; Physician can access unanalyzed information from the patient's electronic logbook
- Group 4: data analyzed intervention (Type: ACTIVE_COMPARATOR): Home diabetes monitoring by patient using mobile phone to communicate information and receive feedback; Physician can access raw and analyzed patient data; Physician receives report summary and treatment recommendations

Based on this trial design, predict the completion outcome and termination type (if applicable).